WO2000025763A3 - Phenolderivaten enthaltendes mittel mit proliferationshemmender wirkung auf tumorzellen - Google Patents

Phenolderivaten enthaltendes mittel mit proliferationshemmender wirkung auf tumorzellen Download PDF

Info

Publication number
WO2000025763A3
WO2000025763A3 PCT/DE1999/003524 DE9903524W WO0025763A3 WO 2000025763 A3 WO2000025763 A3 WO 2000025763A3 DE 9903524 W DE9903524 W DE 9903524W WO 0025763 A3 WO0025763 A3 WO 0025763A3
Authority
WO
WIPO (PCT)
Prior art keywords
proliferation
tumour cells
inhibiting effect
cells
phenol derivatives
Prior art date
Application number
PCT/DE1999/003524
Other languages
English (en)
French (fr)
Other versions
WO2000025763A2 (de
Inventor
Gerhard Bundschuh
Original Assignee
Meckel Spenglersan Gmbh
Gerhard Bundschuh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meckel Spenglersan Gmbh, Gerhard Bundschuh filed Critical Meckel Spenglersan Gmbh
Publication of WO2000025763A2 publication Critical patent/WO2000025763A2/de
Publication of WO2000025763A3 publication Critical patent/WO2000025763A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

Die Erfindung betrifft die Bereitstellung von Mitteln mit proliferationshemmender Wirkung auf Tumorzellen. Die erfindungsgemäßen Mittel enthalten als wirksame Komponenten Phenolderivate, insbesondere Thymol, Eugenol, Hydroxybenzoesäuren bzw. deren Derivate sowie Gemische dieser Komponenten. Als Testzellen sind kultivierbare Tumorzellen menschlicher Herkunft, wie Lymphomzellen oder Melanomzellen, eingesetzt worden.
PCT/DE1999/003524 1998-10-30 1999-10-29 Phenolderivaten enthaltendes mittel mit proliferationshemmender wirkung auf tumorzellen WO2000025763A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19851706.8 1998-10-30
DE19851706 1998-10-30

Publications (2)

Publication Number Publication Date
WO2000025763A2 WO2000025763A2 (de) 2000-05-11
WO2000025763A3 true WO2000025763A3 (de) 2000-11-09

Family

ID=7887244

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1999/003524 WO2000025763A2 (de) 1998-10-30 1999-10-29 Phenolderivaten enthaltendes mittel mit proliferationshemmender wirkung auf tumorzellen

Country Status (2)

Country Link
DE (1) DE19954040A1 (de)
WO (1) WO2000025763A2 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9132103B2 (en) 2009-09-24 2015-09-15 Conopco, Inc. Disinfecting agent comprising eugenol, terpineol and thymol
US9408870B2 (en) 2010-12-07 2016-08-09 Conopco, Inc. Oral care composition

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1909778T3 (en) * 2005-07-28 2018-03-19 Academisch Ziekenhuis Bij De Univ Van Amsterdam Monophenol, benzenediol or sulfhydryl compounds for use in the treatment of melanomas
WO2013064360A2 (en) 2011-11-03 2013-05-10 Unilever N.V. A personal cleaning composition

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4418796A1 (de) * 1993-06-02 1994-12-15 Colgate Palmolive Co Oral anwendbare und gegen Plaque und Gingivitis wirkende Zusammensetzungen
WO1996030003A1 (de) * 1995-03-30 1996-10-03 Werner Kreutz Arzneistoffe zur selektiven bekämpfung von tumorgewebe
US5753270A (en) * 1987-09-16 1998-05-19 Patrick A. Beauchamp Topical treatment of diseased skin disorders
JPH11315012A (ja) * 1998-03-04 1999-11-16 Shiseido Co Ltd サイクリックａｍｐ誘導剤

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753270A (en) * 1987-09-16 1998-05-19 Patrick A. Beauchamp Topical treatment of diseased skin disorders
DE4418796A1 (de) * 1993-06-02 1994-12-15 Colgate Palmolive Co Oral anwendbare und gegen Plaque und Gingivitis wirkende Zusammensetzungen
WO1996030003A1 (de) * 1995-03-30 1996-10-03 Werner Kreutz Arzneistoffe zur selektiven bekämpfung von tumorgewebe
JPH11315012A (ja) * 1998-03-04 1999-11-16 Shiseido Co Ltd サイクリックａｍｐ誘導剤

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
"martindale 30th edition", PHARMACEUTICAL PRESS, XP002134890 *
BUCCELLATO, G. ET AL: "Possible cytolytic activity of p-methylisopropylphenol (thymol)and of som chemically related compounds", BOLL. - SOC. ITAL. BIOL. SPER. (1966), 42(24), 1890-3, XP000901383 *
BUCCELLATO, G.: "Routes of administration of p-methylisopropylphenol (thymol) and its 24-hr. urinary elimination", BOLL. - SOC. ITAL. BIOL. SPER. (1966), 42(24), 1886-90, XP000901382 *
DATABASE CHEMABS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; OTA, MASAHIRO ET AL: "Cyclic AMP inducers for activation of tyrosinase and prevention of hair graying", XP002134891, retrieved from STN Database accession no. 131:327324 *
DATABASE WPI Section Ch Derwent World Patents Index; Class B07, AN 1970-67604R, XP002134892 *
SIVROPOULOU, AFRODITI ET AL: "Antimicrobial and cytotoxic activities of Origanum essential oils", J. AGRIC. FOOD CHEM. (1996), 44(5), 1202-5, XP000583841 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9132103B2 (en) 2009-09-24 2015-09-15 Conopco, Inc. Disinfecting agent comprising eugenol, terpineol and thymol
US9408870B2 (en) 2010-12-07 2016-08-09 Conopco, Inc. Oral care composition

Also Published As

Publication number Publication date
DE19954040A1 (de) 2000-05-04
WO2000025763A2 (de) 2000-05-11

Similar Documents

Publication Publication Date Title
AU747599C (en) Antitumor agents
BG104780A (en) Inhibitors of phospholipase enzymes
MXPA01012336A (es) Gel de silicon que contiene acido salicilico.
HK1036931A1 (en) Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients.
AR020345A1 (es) Pirazol-carboxanilidas, procedimiento para su obtencion, composiciones, empleo de dichos compuestos y procedimiento para la lucha contra microorganismos indeseables, y procedimiento para la obtencion de dichas composiciones.
GEP20063885B (en) Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
AU2613995A (en) Lactobacillus strains of human origin, their compositions and uses thereof
IL140710A0 (en) Pulmonary delivery of active agents
ATE146360T1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
MX9708401A (es) Genes reguladores de la cromatina.
HK1023719A1 (en) Stable compositions containing a retinoid and an enzyme based antioxidant system
AP1424A (en) 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens.
CA2318398A1 (en) Novel peptides having biological activity
SE9201628D0 (sv) Pharmaceutical composition
EP0841065A3 (de) Verwendung von Sericin als Antioxidantien und Tyrosinase-Inhibitoren
AU2003293555A1 (en) 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
WO1997004788A3 (en) Use of calendula glycosides for the treatment of psoriasis
GR3024667T3 (en) Cosmetical or pharmaceutical compositions comprising deacylated glycerophospholipids for topical use.
AU1095901A (en) Tissue products containing antiviral agents which are mild to the skin
NZ319138A (en) Composition containing cytochrome complex III and fenazaquin for combatting parasitic fungi
MY130792A (en) 17ß-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
WO2000025763A3 (de) Phenolderivaten enthaltendes mittel mit proliferationshemmender wirkung auf tumorzellen
AU6849198A (en) Neurotrypsin
GB9923858D0 (en) Antimicrobial compositions

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

122 Ep: pct application non-entry in european phase